Related Experiment Video
Updated: Aug 9, 2026
Real-time Pressure-volume Analysis of Acute Myocardial Infarction in Mice
Published on: July 2, 2018
Initial experience with multivessel percutaneous coronary intervention during mechanical reperfusion for acute
1Duke Clinical Research Institute, Durham, North Carolina 27715, USA. Roe00001@mc.duke.edu
Insights
Multivessel percutaneous coronary intervention during reperfusion for acute myocardial infarction increases adverse outcomes. Limiting intervention to the infarct-related artery is safer in the short term.
Area of Science:
- Cardiology
- Interventional Cardiology
- Acute Myocardial Infarction Research
Background:
- Acute myocardial infarction (AMI) management often involves reperfusion therapy.
- Percutaneous coronary intervention (PCI) is a key reperfusion strategy.
- Multivessel disease is common in AMI patients.
Purpose of the Study:
- To analyze the feasibility and safety of simultaneous multivessel PCI during mechanical reperfusion for AMI.
- To compare clinical outcomes between patients undergoing multivessel PCI versus single-vessel PCI in AMI.
Main Methods:
- Retrospective, case-controlled study design.
- Analysis of patients undergoing mechanical reperfusion for AMI.
- Comparison of outcomes between simultaneous multivessel PCI and single-infarct-related artery PCI groups.
Main Results:
- Multivessel PCI in AMI was associated with a higher risk of adverse clinical outcomes.
- Adverse outcomes were observed up to 6 months post-intervention.
- Matched controls (single-vessel PCI) showed better outcomes.
Conclusions:
- Simultaneous multivessel PCI during mechanical reperfusion for AMI carries increased risks.
- Limiting PCI to the infarct-related artery appears safer in the 6-month follow-up period.
- Further research may be needed to optimize revascularization strategies in multivessel AMI.
Abstract:
The feasibility and safety of simultaneous multivessel percutaneous coronary intervention during mechanical reperfusion for acute myocardial infarction was analyzed in a retrospective, case-controlled study. Patients who underwent multivessel coronary intervention had a higher risk of adverse clinical outcomes through 6 months compared with matched controls in whom coronary intervention was limited to the infarct-related artery.
